Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
NodThera is a biotechnology company focused on the discovery and development of new treatments for diseases.
Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.
Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders.
Twentyeight-Seven Therapeutics is a developer of microRNAs designed to target regulatory proteins.
EnobraQ is a Toulouse-based biotechnology company.
Delinia was founded to discover and develop novel therapeutics for the treatment of autoimmune and inflammatory diseases.
Sofinnova Partners has invested in 150 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sofinnova Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Medical. The firm invests across 10 different industry categories.
Among tracked funding rounds, NodThera received $55.0M in a Series B round. Sofinnova Partners's total known invested capital is $7.1B.
Sofinnova Partners's average investment size is $47.4M across its portfolio of 150 companies.
Recent Sofinnova Partners portfolio additions include NodThera, Corvidia. These companies were founded in 2020 or later.